As of 2026-03-25, the Relative Valuation of Fortress Biotech Inc (FBIO) is 2.99 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.98 USD, the upside of Fortress Biotech Inc based on Relative Valuation is 0.2%.
The range of the Relative Valuation is 2.71 - 3.49 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.3x - 27.2x | 24.5x |
| Forward P/E multiples | 21.1x - 25.6x | 22.0x |
| Fair Price | 2.71 - 3.49 | 2.99 |
| Upside | -9.1% - 17.2% | 0.2% |
| Date | P/E |
| 2026-03-13 | 24.13 |
| 2026-03-12 | 25.54 |
| 2026-03-11 | 25.07 |
| 2026-03-10 | 26.16 |
| 2026-03-09 | 26.24 |
| 2026-03-06 | 26.00 |
| 2026-03-05 | 24.37 |
| 2026-03-04 | 24.13 |
| 2026-03-03 | 23.82 |
| 2026-03-02 | 25.69 |
| 2026-02-27 | 26.63 |
| 2026-02-26 | 27.40 |
| 2026-02-25 | 27.64 |
| 2026-02-24 | 27.56 |
| 2026-02-23 | 26.86 |
| 2026-02-20 | 26.16 |
| 2026-02-19 | 27.09 |
| 2026-02-18 | 26.86 |
| 2026-02-17 | 27.25 |
| 2026-02-13 | 28.10 |
| 2026-02-12 | 27.17 |
| 2026-02-11 | 28.57 |
| 2026-02-10 | 29.19 |
| 2026-02-09 | 28.49 |
| 2026-02-06 | 25.46 |
| 2026-02-05 | 22.81 |
| 2026-02-04 | 23.98 |
| 2026-02-03 | 24.06 |
| 2026-02-02 | 24.52 |
| 2026-01-30 | 24.13 |
| 2026-01-29 | 26.16 |
| 2026-01-28 | 26.31 |
| 2026-01-27 | 26.94 |
| 2026-01-26 | 26.47 |
| 2026-01-23 | 26.47 |
| 2026-01-22 | 27.09 |
| 2026-01-21 | 26.94 |
| 2026-01-20 | 27.09 |
| 2026-01-16 | 28.96 |
| 2026-01-15 | 27.09 |
| 2026-01-14 | 25.54 |
| 2026-01-13 | 30.36 |
| 2026-01-12 | 32.70 |
| 2026-01-09 | 33.48 |
| 2026-01-08 | 34.10 |
| 2026-01-07 | 33.24 |
| 2026-01-06 | 32.78 |
| 2026-01-05 | 33.24 |
| 2026-01-02 | 31.37 |
| 2025-12-31 | 28.49 |